Ishare Pharma Private Limited
About Ishare Pharma Private Limited
Data last updated:
Ishare Pharma Private Limited was a private limited company based in Ghaziabad, Uttar Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 June 2013.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U74110UP2013PTC057953. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It was formerly known as Ishare Solutions Private Limited. It was led by directors Rita Govil and Naman Govil.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 4 Kiran Enclave G. T. Road, Ghaziabad, Uttar Pradesh, India – 201001.
Company details
CIN history
Ishare Pharma has one previous CIN (Corporate Identification Number): U74120UP2013PTC057953. The current CIN is U74110UP2013PTC057953, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110UP2013PTC057953 | Current |
| U74120UP2013PTC057953 | Previous |
Contact details
Ishare Pharma Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4 Kiran Enclave G. T. Road, Ghaziabad, Uttar Pradesh, India – 201001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ishare Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ishare Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Ishare Pharma Private Limited
FY 2024 filings availableIshare Pharma Private Limited reported revenue of ₹2,173 (down 71% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 31% over five years, including a 71% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ishare Pharma Private Limited, buy the company report.
Board of directors of Ishare Pharma Private Limited
Ishare Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rita Govil Also directs: Kay Bee Cold Storage LLP, Parsuram Cements LLP, Allons Promoters Private Limited and 5 more | Director | 06 Aug 2018 | 8 Years 2 Months | As last reported |
| Naman Govil Also directs: Kay Bee Cold Storage LLP, Parsuram Cements LLP, Govil and Associates Private Limited and 3 more | Director | 25 Jun 2013 | 13 Years 4 Months | As last reported |
Auditor
Ishare Pharma Private Limited is audited by A S GOEL & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A S GOEL & Co. | FY 2023 | 017868C |
Shareholding
The shareholding of Ishare Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ishare Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ishare Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ishare Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ishare Pharma has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ishare Pharma Private Limited, buy the company report.
Recent activity
Ishare Pharma Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Akshat Singhal ceased to be Additional Director on 30 Sep 2020.
Frequently asked questions
Ishare Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Ishare Pharma was a private limited company based in Ghaziabad, Uttar Pradesh, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 25 June 2013 and is registered under CIN U74110UP2013PTC057953. The company has been struck off by the Registrar of Companies and is no longer operational.
Ishare Pharma had 2 directors:
- Rita Govil - Director
- Naman Govil - Director
The CIN (Corporate Identification Number) of Ishare Pharma is U74110UP2013PTC057953. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ishare Pharma is at 4 Kiran Enclave G. T. Road, Ghaziabad, Uttar Pradesh, India – 201001.
Ishare Pharma was incorporated on 25 June 2013. It is registered with the Registrar of Companies, Kanpur.
The latest financial statements of Ishare Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Ishare Pharma has 2 GST registrations on record and all of them are cancelled or inactive.
Ishare Pharma operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Akshat Singhal ceased to be Additional Director on 30 Sep 2020. Rita Govil ceased to be Additional Director on 29 Sep 2018. Rishab Jain ceased to be Director on 06 Aug 2018. Ishare Pharma has 5 board changes on record in total.